BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/18/2014 5:14:00 PM | Browse: 1122 | Download: 874
Publication Name World Journal of Gastroenterology
Manuscript ID 10108
Country/Territory Spain
Received
2014-03-14 08:52
Peer-Review Started
To Make the First Decision
Return for Revision
Revised
Second Decision
2014-04-09 09:17
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2014-04-09 10:57
Articles in Press
2014-05-23 09:35
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2014-07-24 16:24
Publish the Manuscript Online
2014-08-18 16:49
ISSN 1007-9327 (print) and 2219-2840 (online)
Open Access
Copyright
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Medicine, Research & Experimental
Manuscript Type Topic Highlights
Article Title Optimizing clarithromycin-containing therapy for Helicobacter pylori in the era of antibiotic resistance
Manuscript Source Invited Manuscript
All Author List Javier Molina-Infante and Javier P Gisbert
Funding Agency and Grant Number
Corresponding Author Javier Molina-Infante, MD, Department of Gastroenterology, Hospital San Pedro de Alcantara, C/ Pablo Naranjo s/n, 10003 Caceres, Spain. xavi_molina@hotmail.com
Key Words Helicobacter pylori; Eradication; Clarithromycin; Sequential; Concomitant; Hybrid; Antibiotic resistance; Bismuth
Core Tip Triple therapy is no longer effective to eradicate Helicobacter pylori infection in most settings across the world. Bismuth quadruple therapy has resurfaced as an ideal replacement, despite its implementation in clinical practice may be troublesome. As such, non-bismuth quadruple therapies remain in the therapeutic front line in clinical practice. This article updates available evidence over the last five years on the efficacy of several non-bismuth quadruple schemes and different tools used to optimize them, providing a novel regionalized therapeutic algorithm, according to novel predicting models based on local antibiotic resistance rates.
Publish Date 2014-08-18 16:49
Citation Molina-Infante J, Gisbert JP. Optimizing clarithromycin-containing therapy for Helicobacter pylori in the era of antibiotic resistance. World J Gastroenterol 2014; 20(30): 10338-10347
URL http://www.wjgnet.com/1007-9327/full/v20/i30/10338.htm
DOI http://dx.doi.org/10.3748/wjg.v20.i30.10338
Full Article (PDF) WJG-20-10338.pdf
Full Article (Word) WJG-20-10338.doc
Manuscript File 10108-Review.docx
Answering Reviewers 10108-Answering reviewers.pdf
Copyright License Agreement 10108-Copyright assignment.pdf
Peer-review Report 10108-Peer review(s).pdf
Scientific Editor Work List 10108-Scientific editor work list.doc